The increase in institutional ownership from a major custodian bank is a routine passive filing. Monitor for any future 13D conversion if State Street's activity pattern changes, but no near-term catalyst is indicated.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $4.81entry
- T+1 · 6d ago +1.25%α −0.07% · $4.87
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corp filed a Schedule 13G disclosing a passive 4.1% stake (6,723,774 shares) in Ironwood Pharmaceuticals as of September 30, 2026. This is an increase from the 3.2% stake reported by Bank of America in late October, though State Street's prior filing (August 2026) did not include a stake percentage in the provided context. The filing is routine and passive, with no activist intent.
Key Financial Metrics
Key Facts
- State Street Corp disclosed a 4.1% passive stake in Ironwood Pharmaceuticals as of September 30, 2026.
- Total beneficial ownership: 6,723,774 shares of common stock.
- Sole voting power: 0 shares; shared voting power: 6,516,093 shares; sole dispositive power: 0 shares; shared dispositive power: 6,723,774 shares.
- The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
- This follows a prior SC 13G/A by Bank of America on October 28, 2026, disclosing a 3.2% passive stake.
Financial Impact
State Street's stake of 6,723,774 shares represents 4.1% of Ironwood's outstanding shares, valued at approximately $29.8M based on the $727M market cap.
Risk Factors
- No activist intent is signaled; this is a standard passive disclosure by a large asset manager.
- The filing does not provide a comparison to State Street's prior stake, so the direction of change is not fully clear from the document alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000678 |
| Document: 0000093751-26-000678-index.html | 0000093751-26-000678 |
| Document: 0000093751-26-000678.txt | 0000093751-26-000678 |
Track record
13 reports on IRWD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +20.35% at T+5 after the Nov 5, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $4.88 Now $4.85 −0.51% settles Dec 15
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $4.84 Now $4.85 +0.21% settles Dec 15
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $4.81 Now $4.85 +0.83% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $4.81 Now $4.85 +0.83% settles Dec 9
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $4.03 Now $4.85 +20.35% settles Dec 4
- Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $3.61 Now $4.85 +34.35% settles Nov 25
- Oct 16, 20264w ago 8-K Neutral 3/10 Entry $3.50 to $4.85 Now $4.85 +38.57% ▲ +38.57% +39.73% vs SPY
- Aug 6, 202614w ago 8-K Bullish 7/10 Entry $4.26 to $4.29 Now $4.85 +13.85% ▲ +0.70% +0.10% vs SPY
- May 13, 202626w ago 8-K Mixed 6/10 Entry $3.68 to $3.63 Now $4.85 +31.79% ▼ −1.36% −0.75% vs SPY
- May 7, 202627w ago 8-K Bullish 7/10 Entry $4.17 to $3.24 Now $4.85 +16.31% ▼ −22.30% −25.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers